VRTXHealthcareLarge-Cap

VERTEX PHARMACEUTICALS INC / MA Insider Trading Activity

Every SEC Form 4 insider transaction reported for VERTEX PHARMACEUTICALS INC / MA (VRTX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are VRTX insiders buying or selling?

VERTEX PHARMACEUTICALS INC / MA insiders reported 5 open-market buys ($14.0M) and 525 sells ($967.5M) across 530 Form 4 filings — a net selling position of $953.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 7, 2026)

Total Form 4 filings
530
SEC EDGAR
Insider filers
26
Insider buys (5)
$14.0M
Insider sells (525)
$967.5M

Insider sentiment

Net selling

Net insider flow of $953.5M in net selling.

Recent VRTX insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 7, 2026Ourania TatsisEVP, Chief Reg. & Quality Off.Sale1.5K$524.99$787.5K
Jul 7, 2026Duncan MckechnieEVP, Chief Commercial OfficerSale1.5K$519.00$799.8K
Jul 6, 2026Joy LiuEVP and Chief Legal OfficerSale828$502.71$416.2K
Jun 30, 2026Carmen BozicEVP and CMOSale596$482.50$287.6K
Jun 23, 2026Carmen BozicEVP and CMOSale1.0K$462.17$471.4K
Jun 17, 2026Carmen BozicEVP and CMOSale4.1K$450.00$1.8M
Jun 9, 2026Carmen BozicEVP and CMOSale1.7K$450.00$785.3K
Jun 3, 2026Joy LiuEVP and Chief Legal OfficerSale828$439.91$364.2K
Jun 2, 2026Carmen BozicEVP and CMOSale2.0K$450.00$888.3K
May 19, 2026Mark E. BunnageEVP, Chief Scientific OfficerSale33$453.45$15.0K
May 19, 2026Carmen BozicEVP and CMOSale1.4K$453.45$614.0K
May 14, 2026Carmen BozicEVP and CMOSale7.0K$450.00$3.1M
May 5, 2026Joy LiuEVP and Chief Legal OfficerSale1.1K$425.02$469.2K
May 5, 2026Sangeeta N. BhatiaDirectorSale318$423.73$134.7K
Apr 3, 2026Joy LiuEVP and Chief Legal OfficerSale978$449.17$439.3K
Mar 31, 2026Carmen BozicEVP and CMOSale2.3K$450.95$1.1M
Mar 17, 2026Carmen BozicEVP and CMOSale2.3K$481.79$1.1M
Mar 13, 2026Duncan MckechnieEVP, Chief Commercial OfficerSale2.6K$498.42$1.3M
Mar 6, 2026Duncan MckechnieEVP, Chief Commercial OfficerSale2.4K$475.30$1.2M
Mar 4, 2026Joy LiuEVP and Chief Legal OfficerSale892$495.96$442.4K
Mar 3, 2026Reshma KewalramaniCEO & PresidentSale40.0K$493.47$19.7M
Mar 3, 2026Carmen BozicEVP and CMOSale2.3K$480.31$1.1M
Mar 2, 2026Kristen AmbroseSVP & Chief Accounting OfficerSale357$483.36$172.6K
Feb 26, 2026Ourania TatsisEVP, Chief Reg. & Quality Off.Sale260$486.35$126.5K
Feb 26, 2026Amit SachdevEVP Chief Patient & Ext Af OffSale1.8K$486.35$897.8K

Showing the 25 most recent of 530 Form 4 filings for VERTEX PHARMACEUTICALS INC / MA.

Most active VRTX insiders

  • David Altshuler67 filings
  • Stuart A Arbuckle56 filings
  • Michael Parini50 filings
  • Amit Sachdev43 filings
  • Ourania Tatsis39 filings

Ask anything about VRTX insider activity

Use Trabud's AI agent to query VERTEX PHARMACEUTICALS INC / MA's Form 4 history in plain English — "Show me VRTX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

VRTX insider trading FAQ

Are VERTEX PHARMACEUTICALS INC / MA insiders buying or selling?

Across 530 SEC Form 4 filings, VERTEX PHARMACEUTICALS INC / MA (VRTX) insiders reported 5 open-market purchases totaling $14.0M and 525 sales totaling $967.5M. That is a net selling position of $953.5M.

How many insiders trade VRTX stock?

26 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for VERTEX PHARMACEUTICALS INC / MA. The most recent filing was accepted on Jul 7, 2026.

Where does Trabud get VRTX insider trading data?

All VRTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content